Millions of people worldwide struggle with sleep disorders, compromising their health and quality of life. These conditions often coexist with mental health issues, neuropathic pain and other medical problems. However, a groundbreaking study published in the Journal of Neuroscience offers new hope.
Researchers at McGill University and the University of Padua have made a significant breakthrough in understanding melatonin’s role in treating sleep disorders and related mental health conditions. Their findings reveal the crucial function of the melatonin MT1 receptor in regulating sleep, particularly during the rapid eye movement (REM) stage.